PRKG2 and acromesomelic dysplasia: This is explained by the fact that the first articles linking pathogenic PRKG2 variants to acromesomelic dysplasia emerged only in 2021, while our patient’s panel analysis was conducted in 2022, prior to the gene’s inclusion.